This review highlights tirzepatide, a novel dual agonist of GLP-1 and GIP receptors, which has demonstrated significant improvements in glycemic control, weight loss, and potential cardiovascular and renal benefits, marking it as a promising advancement in T2D treatment
Together, they help shift your body from stress and depletion into rest and repair
Amie Hornaman, author of the bestselling book The Thyroid Fix, to learn what could really be causing fatigue, weight gain, and low energy and why you may need to address your thyroid health before considering GLP-1 medications
Overall agreement 90%: A+ 70%, A 20%, A 0%, D 10%, D 0%, D+ 0%
Brazil's National Health Surveillance Agency (Anvisa) has approved the first semaglutide slimming pen produced in the country